🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Did you know that monoamine oxidases (MAOs) play a crucial role in the degradation of neurotransmitters in our brain? Imbalance in these neurotransmitters is linked to neurological disorders. Exciting research sheds light on the mechanisms behind MAO inhibition. #scicommUU23

Ever wondered why propargylamine inhibitors like rasagiline and selegiline are used to treat neurological disorders? Discover how these inhibitors target monoamine oxidases and prevent the degradation of neurotransmitters, contributing to improved cognitive health. #scicommUU23

Exciting breakthrough! Empirical valence bond simulations have revealed the molecular mechanisms behind MAO inhibition, offering valuable insights into the design of improved inhibitors. This knowledge brings us closer to more effective treatments for brain diseases. #scicommUU23

Unlocking the secrets of MAO inhibition: Scientists have investigated the rate-limiting step in the process, shedding light on the higher reactivity of selegiline compared to rasagiline. These findings pave the way for the development of safer inhibitors. #scicommUU23

Understanding the molecular details of MAO inhibition is essential for developing targeted therapies. Recent studies have provided valuable clues, confirming rasagiline and selegiline as irreversible inhibitors. Exciting prospects lie ahead for improved drug design. #scicommU23

Designing better inhibitors for neurodegenerative conditions is a top priority. Groundbreaking research has unraveled the mechanism behind MAO inhibition and identified key factors influencing inhibitor reactivity. #scicommU23

Our GPCR ligand binding affinity prediction models on GPCRs presented by Tana Tandarić and Rosalie Drinkwaard at the Free Energy Workshop in Leiden #alchemy2024 #gpcr #cadd